Status:
COMPLETED
A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida
Lead Sponsor:
University of Miami
Collaborating Sponsors:
University of Florida
Conditions:
Cystic Fibrosis
Pediatrics
Eligibility:
All Genders
Up to 18 years
Brief Summary
To determine the prevalence of nontuberculous mycobacterial infection (NTM) in pediatric patients with cystic fibrosis in the State fo Florida. HYPOTHESIS: There is high prevalence of NTM in CF pediat...
Detailed Description
Non-tuberculous Mycobacteria (NTM) are a heterogeneous group of organisms that have been increasingly reported in North America 1, 2 and recognized to be a pulmonary pathogen in non immunocompromised ...
Eligibility Criteria
Inclusion
- Patients that have a diagnosis of Cystic Fibrosis and are 18 or below years of age
Exclusion
- Patients that are above 18 years of age and or patients that do not have the diagnosis of Cystic fibrosis
Key Trial Info
Start Date :
March 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT02198079
Start Date
March 1 2010
End Date
March 1 2015
Last Update
May 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami, Miller School of Medicine
Miami, Florida, United States, 33136